Drug Trial Radar · NCT04875026
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
Last checked: Nov 20, 2026Latest source record: Sep 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
146
Actual
Start
Feb 16, 2021
Primary completion
Jan 31, 2022
Study completion Jan 31, 2022
Sponsor
- Lead sponsor
- Pierre Fabre MedicamentIndustry
- Sponsor type
- Industry
- Collaborators
- Clinact
- First posted
- May 6, 2021
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Supportive care
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Transient local skin reactions with topical Actinic Keratosis treatments such as 5-FluoroUracil (5-FU) often lead to non-adhesion from patients and thus to treatment failure. In regards to 5-FU treatment, these local reactions are related to the pharmacological action of the molecule. The current therapeutic challenge is to reduce the local reactions induced by 5-FU without interfering with its efficacy, in particular by the use of an emollient cream. The aim of the present study is to investigate how the use of an emollient, namely Dexeryl, could improve the local skin reactions occurring during 4 weeks of a 4% 5-FU treatment.
Conditions
- Actinic Keratoses
Interventions
5-fluorouracil 4% (Tolak)Drug
Application of Tolak once daily in the evening for 4 weeks
DexerylDevice
Application of Dexeryl once daily in the morning for 8 weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Local Skin Reaction (LSR) total scoreTime frame: at 4 weeks or Last Observation Carried Forward (LOCF)
Locations
27 sites in 4 countries. Site status is shown where the registry gives one.
Private practice Maire
Arras, France
Chu de Nantes Hôtel-Dieu
Nantes, France
CHU Pau
Pau, France
CHU Poitiers
Poitiers, France
CHU St Etienne Hopital Nord
Saint-Etienne, France
Kath. Klinikum Bochum St. Josef-Hospital
Bochum, Germany
MVZ Dermatologisches Zentrum Bonn GmbH
Bonn, Germany
Private practice Quist
Bretzenheim, Germany
Private Practice Kurzen
Freising, Germany
Dermatologikum Hamburg
Hamburg, Germany
Hautarztpraxis
Witten, Germany
CentroDerm Clinic
Witten, Germany
Uni Clinic Brescia
Brescia, Italy
Uni Clinic Catania
Catania, Italy
Uni Clinic L'Aquila
Coppito, Italy
Policlinico San Martino
Genova, Italy
University of Messina
Messina, Italy
Uni Clinic Modena
Modena, Italy
NAPLES VANVITELLI UNIVERSITI (Federico II Hospital)
Naples, Italy
Azienda Unità Sanitaria Locale - IRCCS
Reggio Emilia, Italy
Catholic University Fondazione Policlinico Universitario A. Gemelli
Roma, Italy
Sapienza University of Rome - Polo Pontino
Terracina, Italy
Centre medic Congres
Barcelona, Spain
Hospital Alfredo Espinosa
Bilbao, Spain
Hospital Universitario Infanta Leonor
Madrid, Spain
Instituto Valenciano de Oncología,
Valencia, Spain
Hospital Marina Baixa
Villajoyosa, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.